Home/Filings/4/0001140361-23-054744
4//SEC Filing

SCHACHLE JOSEPH K 4

Accession 0001140361-23-054744

CIK 0001228627other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 6:24 PM ET

Size

5.4 KB

Accession

0001140361-23-054744

Insider Transaction Report

Form 4
Period: 2023-11-27
SCHACHLE JOSEPH K
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-11-27+300,000300,000 total
    Exercise: $2.79Exp: 2033-11-26Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]The option will vest with respect to 25% on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each full month over the subsequent 36 months, subject to continuing service.

Documents

1 file

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001145914

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 6:24 PM ET
Size
5.4 KB